Biotricity, Inc. (BTCY) Q4 2025 Earnings Conference Call Transcript

Group 1 - The core viewpoint of the earnings call is that Biotricity has experienced a transformative fiscal year 2025, with significant advancements and strategic initiatives leading towards profitability and positive EBITDA [4]. - The company has made remarkable progress through innovation, strategic partnerships, and operational efficiency [4]. - A major achievement highlighted is the expansion of Biotricity's Cardiac AI cloud platform, supported by partnerships with industry leaders [5].